{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T10:31:53Z","timestamp":1726482713407},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["R01MH085635"],"award-info":[{"award-number":["R01MH085635"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.pnpbp.2013.10.005","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T19:01:45Z","timestamp":1381950105000},"page":"177-185","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood"],"prefix":"10.1016","volume":"48","author":[{"given":"Jing","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.10.005_bb0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0893-133X(02)00327-5","article-title":"Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats","volume":"27","author":"Addy","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B","article-title":"Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats","volume":"37","author":"Andersen","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2011.09.008","article-title":"Adolescent social defeat increases adult amphetamine conditioned place preference and alters D2 dopamine receptor expression","volume":"197","author":"Burke","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0269881109354929","article-title":"Multiple \u2018hits\u2019 during postnatal and early adulthood periods disrupt the normal development of sensorimotor gating ability in rats","volume":"25","author":"Chen","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.euroneuro.2009.09.002","article-title":"Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats","volume":"20","author":"Choi","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.103.057158","article-title":"Recovery of sensorimotor gating without G protein adaptation after repeated D2-like dopamine receptor agonist treatment in rats","volume":"308","author":"Culm","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-6-18","article-title":"Commentary on strategies for switching antipsychotics","volume":"6","author":"Davis","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0040","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1176\/ajp.2006.163.12.2090","article-title":"Effectiveness of switching antipsychotic medications","volume":"163","author":"Essock","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0045","first-page":"178","article-title":"Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm","volume":"238C","author":"Feng","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbr.2012.10.009","article-title":"Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm","volume":"238","author":"Feng","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0055","first-page":"583","article-title":"Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study","volume":"49","author":"Findling","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005053-197411000-00004","article-title":"Are antipsychotic drugs interchangeable?","volume":"159","author":"Gardos","year":"1974","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0070","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0028-3908(87)90245-0","article-title":"Quinpirole hydrochloride, a potential anti-parkinsonism drug","volume":"26","author":"Koller","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(84)91218-6","article-title":"Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems","volume":"303","author":"Koob","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/schbul\/sbm109","article-title":"Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia","volume":"34","author":"Kumra","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.npp.1301110","article-title":"Time course of the antipsychotic effect and the underlying behavioral mechanisms","volume":"32","author":"Li","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FBP.0b013e32832a8f66","article-title":"An investigation of the behavioral mechanisms of antipsychotic action using a drug\u2013drug conditioning paradigm","volume":"20","author":"Li","year":"2009","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FBP.0b013e3283243008","article-title":"Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus","volume":"20","author":"Li","year":"2009","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-010-1925-5","article-title":"Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning","volume":"212","author":"Li","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pbb.2011.03.007","article-title":"Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment","volume":"98","author":"Li","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pbb.2011.05.001","article-title":"Time course of prepulse inhibition disruption induced by dopamine agonists and NMDA antagonists: effects of drug administration regimen","volume":"99","author":"Li","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00702-011-0722-6","article-title":"Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A\/2C receptors","volume":"119","author":"Li","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00702-011-0722-6","article-title":"Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT(2A\/2C) receptors","volume":"119","author":"Li","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0125","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuropharm.2011.07.031","article-title":"Neurobehavioral and metabolic long-term consequences of neonatal maternal deprivation stress and adolescent olanzapine treatment in male and female rats","volume":"62","author":"Llorente-Berzal","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0135","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/0269881109102546","article-title":"Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism","volume":"24","author":"Mead","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0140","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs","volume":"25","author":"Meltzer","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0145","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/schbul\/sbn131","article-title":"Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia","volume":"36","author":"Meyer","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0155","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1046\/j.1460-9568.1999.00858.x","article-title":"Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat","volume":"11","author":"Millan","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/syn.20220","article-title":"Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects","volume":"59","author":"Moran-Gates","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0170","first-page":"51","article-title":"Preclinical measurement of the amount of state-dependent learning produced by psychoactive drugs [proceedings]","volume":"15","author":"Overton","year":"1979","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0175","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.chi.0000157543.74509.c8","article-title":"Trends in the use of typical and atypical antipsychotics in children and adolescents","volume":"44","author":"Patel","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0190","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/schbul\/sbq040","article-title":"Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia","volume":"37","author":"Piontkewitz","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-008-1308-3","article-title":"Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies","volume":"203","author":"Porter","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00634463","article-title":"Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride","volume":"99","author":"Prosser","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0205","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/npp.2012.213","article-title":"Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model","volume":"38","author":"Qiao","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuropharm.2013.05.031","article-title":"Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity","volume":"75C","author":"Qin","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2008.09.031","article-title":"Does switching to a new antipsychotic improve outcomes? Data from the CATIE trial","volume":"107","author":"Rosenheck","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00429551","article-title":"Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats","volume":"42","author":"Schechter","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0225","first-page":"004","article-title":"Is brain-derived neurotrophic factor a possible mechanism underlying risperidone sensitization in adolescent rats","volume":"S1","author":"Shu","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0230","article-title":"Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model","author":"Shu","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0235","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study","volume":"165","author":"Sikich","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0240","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.chc.2012.07.010","article-title":"The neural effects of psychotropic medications in children and adolescents","volume":"21","author":"Singh","year":"2012","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0245","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejphar.2008.11.036","article-title":"Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs","volume":"602","author":"Sun","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0250","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pbb.2010.02.005","article-title":"Anxiolytic-like property of risperidone and olanzapine as examined in multiple measures of fear in rats","volume":"95","author":"Sun","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0255","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/FBP.0b013e32835651ea","article-title":"Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test\u2013retest interval","volume":"23","author":"Swalve","year":"2012","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","article-title":"Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon","volume":"11","author":"Swerdlow","year":"2000","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-3806(95)00109-Q","article-title":"Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens","volume":"89","author":"Teicher","year":"1995","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0270","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","article-title":"A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia","volume":"30","author":"Vuillermot","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-7634(99)00037-8","article-title":"The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?","volume":"23","author":"Wadenberg","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-3223(90)90657-N","article-title":"Suppression of conditioned avoidance behavior by the local application of (\u2212)sulpiride into the ventral, but not the dorsal, striatum of the rat","volume":"28","author":"Wadenberg","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(93)90194-R","article-title":"Responses of rat striatal neurons during performance of a lever-release version of the conditioned avoidance response task","volume":"616","author":"White","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0290","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/FBP.0b013e32834ecac4","article-title":"Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine","volume":"23","author":"Zhang","year":"2012","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.10.005_bb0295","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pbb.2010.12.018","article-title":"Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence","volume":"98","author":"Zhang","year":"2011","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T22:26:39Z","timestamp":1564525599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":57,"alternative-id":["S0278584613002212"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.10.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}